Lundstedt T - Search Results

1

Neuroprotective effects of melanocortins in CNS injury.

Sharma HS, Lundstedt T, Flärdh M, Skottner A, Wiklund L. Sharma HS, et al. Among authors: lundstedt t. Curr Pharm Des. 2007;13(19):1929-41. doi: 10.2174/138161207781039797. Curr Pharm Des. 2007. PMID: 17627526 Review.

2

Low molecular weight compounds with affinity to melanocortin receptors exert neuroprotection in spinal cord injury--an experimental study in the rat.

Sharma HS, Lundstedt T, Flärdh M, Westman J, Post C, Skottner A. Sharma HS, et al. Among authors: lundstedt t. Acta Neurochir Suppl. 2003;86:399-405. doi: 10.1007/978-3-7091-0651-8_84. Acta Neurochir Suppl. 2003. PMID: 14753476

3

Neuroprotective effects of melanocortins in experimental spinal cord injury. An experimental study in the rat using topical application of compounds with varying affinity to melanocortin receptors.

Sharma HS, Skottner A, Lundstedt T, Flärdh M, Wiklund L. Sharma HS, et al. Among authors: lundstedt t. J Neural Transm (Vienna). 2006 Apr;113(4):463-76. doi: 10.1007/s00702-005-0404-3. J Neural Transm (Vienna). 2006. PMID: 16550325

4

Drug delivery to the spinal cord tagged with nanowire enhances neuroprotective efficacy and functional recovery following trauma to the rat spinal cord.

Sharma HS, Ali SF, Dong W, Tian ZR, Patnaik R, Patnaik S, Sharma A, Boman A, Lek P, Seifert E, Lundstedt T. Sharma HS, et al. Among authors: lundstedt t. Ann N Y Acad Sci. 2007 Dec;1122:197-218. doi: 10.1196/annals.1403.014. Ann N Y Acad Sci. 2007. PMID: 18077574

5

Nanowired-drug delivery enhances neuroprotective efficacy of compounds and reduces spinal cord edema formation and improves functional outcome following spinal cord injury in the rat.

Sharma HS, Ali SF, Tian ZR, Patnaik R, Patnaik S, Sharma A, Boman A, Lek P, Seifert E, Lundstedt T. Sharma HS, et al. Among authors: lundstedt t. Acta Neurochir Suppl. 2010;106:343-50. doi: 10.1007/978-3-211-98811-4_63. Acta Neurochir Suppl. 2010. PMID: 19812975

6

Nano-drug delivery and neuroprotection in spinal cord injury.

Sharma HS, Ali S, Tian ZR, Patnaik R, Patnaik S, Lek P, Sharma A, Lundstedt T. Sharma HS, et al. Among authors: lundstedt t. J Nanosci Nanotechnol. 2009 Aug;9(8):5014-37. doi: 10.1166/jnn.2009.gr04. J Nanosci Nanotechnol. 2009. PMID: 19928182

7

A potent serotonin-modulating compound AP-267 attenuates morphine withdrawal-induced blood-brain barrier dysfunction in rats.

Sharma HS, Lundstedt T, Boman A, Lek P, Seifert E, Wiklund L, Ali SF. Sharma HS, et al. Among authors: lundstedt t. Ann N Y Acad Sci. 2006 Aug;1074:482-96. doi: 10.1196/annals.1369.049. Ann N Y Acad Sci. 2006. PMID: 17105947

8

Nanowired drug delivery to enhance neuroprotection in spinal cord injury.

Tian ZR, Sharma A, Nozari A, Subramaniam R, Lundstedt T, Sharma HS. Tian ZR, et al. Among authors: lundstedt t. CNS Neurol Disord Drug Targets. 2012 Feb;11(1):86-95. doi: 10.2174/187152712799960727. CNS Neurol Disord Drug Targets. 2012. PMID: 22385571 Review.

9

Anti-inflammatory potential of melanocortin receptor-directed drugs.

Skottner A, Post C, Ocklind A, Seifert E, Liutkevicius E, Meskys R, Pilinkiene A, Biziuleviciene G, Lundstedt T. Skottner A, et al. Among authors: lundstedt t. Ann N Y Acad Sci. 2003 Jun;994:84-9. doi: 10.1111/j.1749-6632.2003.tb03165.x. Ann N Y Acad Sci. 2003. PMID: 12851301

10

The novel guanidine ME10092 protects the heart during ischemia-reperfusion.

Dambrova M, Veveris M, Cirule H, Pugovichs O, Post C, Lundstedt T, Kalvinsh I, Skottner A, Wikberg JE. Dambrova M, et al. Among authors: lundstedt t. Eur J Pharmacol. 2002 Jun 7;445(1-2):105-13. doi: 10.1016/s0014-2999(02)01596-0. Eur J Pharmacol. 2002. PMID: 12065201

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

43 results

Search Page

Filters